| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Seth Lederman is Chief Executive Officer at TNXP. Seth Lederman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $57K at current prices.
Historically, Seth Lederman's trades have earned a below-average insider score of 28/100 across 8 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -77.3%.
Net of sales, the TNXP filings show accumulation of 496,533 shares.
Seth Lederman has 38 Form 4 filings on record from October 2016 to August 2026, all as Chief Executive Officer at Tonix Pharmaceuticals (TNXP), 2016–2026.
The 59 reported transactions were 29 open-market purchases, 27 option or other derivative awards and 3 other transactions.
Counted by filing, the open-market trades come to 25 purchases worth about $1.0M and no sales.
The largest open-market purchase was 15,000 shares of TNXP at an average $14.89 on March 18, 2026, about $223K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 2,000 | $13.79 | $27,580.00 | +22.2% | - | - | |
| Jun 9, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 5,000 | $11.79 | $58,950.00 | +124.8% | +14.8% | - | |
| Mar 31, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 5,000 | $12.62 | $63,100.00 | +33.3% | -7.3% | - | |
| Mar 18, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 15,000 | $14.89 | $223,350.00 | +1,500,000% | -18.0% | - | |
| May 15, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 4,000 | $21.55 | $86,200.00 | +80,000% | +166.5% | -31.9% | |
| Jun 29, 2022 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 20,000 | $1.71 | $34,200.00 | +472.3% | -67.7% | -84.6% | |
| Mar 25, 2022 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 100,000 | $0.25 | $24,500.00 | +821.2% | -73.0% | -92.2% | |
| Sep 28, 2021 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 12,000 | $0.61 | $7,320.00 | +6,780% | -33.5% | -97.0% | |
| Mar 24, 2021 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 16,733 | $1.32 | $22,087.56 | +14.1% | -10.5% | -80.8% | |
| Dec 30, 2020 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 35,000 | $0.68 | $23,800.00 | +42.0% | - | - |